NCT05792696

Brief Summary

Intraoperative hypotension is closely related to the poor prognosis of surgery. The study is focused on the effectiveness of maintaining normal peripheral perfusion index (PPI) on time-weighted average of hypotension during anesthesia.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 19, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 31, 2023

Completed
9 months until next milestone

Study Start

First participant enrolled

January 1, 2024

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

October 9, 2024

Status Verified

December 1, 2023

Enrollment Period

1.5 years

First QC Date

March 19, 2023

Last Update Submit

October 7, 2024

Conditions

Keywords

Intraoperative hypotensionPeripheral perfusion indexIGeneral anesthesiaNon-cardiac surgery

Outcome Measures

Primary Outcomes (1)

  • time-weighted average of hypotension (TWA)<65mmHg

    total area under MAP\<65 mmHg/surgery length

    Intraoperative (between anesthesia induction and tracheal extubation)

Secondary Outcomes (10)

  • Rate of hypotension after anesthesia induction

    from anesthesia induction to 15 minutes after then

  • Cumulative number of intraoperative hypotension episodes

    Intraoperative (between anesthesia induction and tracheal extubation)

  • Cumulative time of intraoperative hypotension period

    Intraoperative (between anesthesia induction and tracheal extubation)

  • Proportion of time with hypotension

    Intraoperative (between anesthesia induction and tracheal extubation)

  • time-weighted average of hypertension (TWA)>100mmHg

    Intraoperative (between anesthesia induction and tracheal extubation)

  • +5 more secondary outcomes

Study Arms (2)

PPI guided strategies

EXPERIMENTAL

The decision making for prevention and treatment of hypotension was PPI guided to maintain the PPI between 1 and 3.

Behavioral: PPI guided strategies

conventional strategies

OTHER

The decision making for prevention and treatment of hypotension dependent on the experience of anesthesiologist.

Behavioral: Empirical strategies

Interventions

For targeted MAP or lower, if PPI\<1, more fluid therapy. if PPI\>3, vasoconstriction therapy. For MAP\<65mmHg and 1\<=PPI\<3, test bolus of 250 ml crystalloid fluid.

PPI guided strategies

Fluid therapy or vasoconstriction depended on experiences of anesthetic staffs.

conventional strategies

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • years and older ASA Physical Status 1-3 general anesthesia arterial catheterization procedures last more than 2 hours communicate normally in Mandarin

You may not qualify if:

  • abnormal Allen's test higher target than 65 mmHg history of diabetes vascular diseases arrhythmia cardiac function class II and above physical disability, unable to conduct PPI monitoring participated in other clinical studies in the past month

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhiqiang Zhou

Wuhan, 430030, China

RECRUITING

Study Officials

  • Zhiqiang Zhou

    Tongji Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Zhiqiang Zhou, Dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 19, 2023

First Posted

March 31, 2023

Study Start

January 1, 2024

Primary Completion

June 30, 2025

Study Completion

June 30, 2025

Last Updated

October 9, 2024

Record last verified: 2023-12

Locations